Paramount Cosmet

Who are in the management team of Paramount Cosmet?

As of March 2022, the management team of Paramount Cosmet includes Hitesh Topiwaala (Managing Director), V N Mehta (Non-Executive & Independent Director), Aarti Topiwala (Non-Executive & Non-Independent Director), and Reshma M (Company Secretary & Compliance Officer). Hitesh Topiwaala receives a remuneration of Rs. 83.0 lacs, while the others do not receive any remuneration.

As of March 2022, the management team of Paramount Cosmet includes the following individuals:<BR><BR>1. Hitesh Topiwaala - Managing Director, with a remuneration of Rs. 83.0 lacs.<BR>2. V N Mehta - Non-Executive & Independent Director, with no remuneration.<BR>3. Aarti Topiwala - Non-Executive & Non-Independent Director, with no remuneration.<BR>4. Reshma M - Company Secretary & Compliance Officer, with no remuneration. <BR><BR>This team plays a crucial role in the governance and operational oversight of the company.

Has Paramount Cosmet declared dividend?

Yes, Paramount Cosmetics (India) Ltd declared a 5% dividend (0.5 per share) on September 21, 2017, but the current dividend yield is 0%. Total returns over various periods show mixed performance, with significant gains over longer durations despite some negative returns in shorter time frames.

Yes, Paramount Cosmetics (India) Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 5%<BR>- Amount per share: 0.5<BR>- Ex-date: 21 Sep 17<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -26.04%, the dividend return was 0%, resulting in a total return of -26.04%.<BR><BR>In the 1-year period, the price return was 3.54%, the dividend return was 0%, resulting in a total return of 3.54%.<BR><BR>In the 2-year period, the price return was 8.89%, the dividend return was 0%, resulting in a total return of 8.89%.<BR><BR>In the 3-year period, the price return was -27.07%, the dividend return was 0%, resulting in a total return of -27.07%.<BR><BR>In the 4-year period, the price return was 106.32%, the dividend return was 0%, resulting in a total return of 106.32%.<BR><BR>In the 5-year period, the price return was 241.76%, the dividend return was 0%, resulting in a total return of 241.76%.<BR><BR>Overall, while Paramount Cosmetics declared a dividend in the past, the current dividend yield stands at 0%. The total returns over various periods show a mix of performance, with significant gains over longer periods despite some negative returns in shorter time frames.

What is the technical trend for Paramount Cosmet?

As of June 6, 2025, Paramount Cosmet's technical trend is mildly bearish, indicated by bearish weekly moving averages and MACD, despite a mildly bullish KST on the weekly chart.

As of 6 June 2025, the technical trend for Paramount Cosmet has changed from bearish to mildly bearish. The weekly MACD remains bearish, while the monthly MACD shows a mildly bearish stance. Both the weekly and monthly Bollinger Bands indicate a mildly bearish trend. Daily moving averages are bearish, suggesting short-term weakness. The KST shows a mildly bullish signal on the weekly chart but is mildly bearish on the monthly. Dow Theory indicates a mildly bullish trend on the weekly but no trend on the monthly. Overall, the current technical stance is mildly bearish, driven primarily by the bearish moving averages and the bearish MACD on the weekly timeframe.

Who are the peers of the Paramount Cosmet?

Paramount Cosmet's peers include Hipolin, Sinnar Bidi Udy., KMG Milk Food, Novateor Research, Tasty Dairy, BKV Industries, Octavius Plant, and Shanthala FMCG. Most peers exhibit below average management risk and growth, with KMG Milk Food showing the highest 1-year return at 44.01%, while Paramount Cosmet's return is -1.87%.

Peers: The peers of Paramount Cosmet are Hipolin, Sinnar Bidi Udy., KMG Milk Food, Novateor Resear., Tasty Dairy, BKV Industries, Octavius Plant., and Shanthala FMCG.<BR><BR>Quality Snapshot: Below Average management risk is observed at Hipolin, Sinnar Bidi Udy., Novateor Resear., Tasty Dairy, Paramount Cosmet, and Shanthala FMCG, while Average management risk is found at Octavius Plant. KMG Milk Food and BKV Industries do not qualify for management risk assessment. For growth, Below Average ratings are noted for Hipolin, Sinnar Bidi Udy., Novateor Resear., Paramount Cosmet, and Shanthala FMCG, while Average growth is seen at Tasty Dairy. KMG Milk Food and BKV Industries do not qualify for growth assessment. In terms of capital structure, Below Average ratings are given to Hipolin, Sinnar Bidi Udy., Novateor Resear., Tasty Dairy, Paramount Cosmet, and Shanthala FMCG, while Average capital structure is noted for Octavius Plant. KMG Milk Food and BKV Industries do not qualify for capital structure assessment.<BR><BR>Return Snapshot: The peer with the highest 1-year return is KMG Milk Food at 44.01%, while the lowest is Shanthala FMCG at 0.00%. Paramount Cosmet's 1-year return is -1.87%, which is lower than KMG Milk Food's but higher than Shanthala FMCG's. Additionally, the six-month returns for Hipolin, Tasty Dairy, Octavius Plant., and Shanthala FMCG are negative.

What does Paramount Cosmet do?

Paramount Cosmetics (India) Ltd is a micro-cap FMCG company that manufactures and markets cosmetic products. As of March 2025, it reported net sales of 60 Cr and a net profit of 0 Cr, with a market cap of INR 21 Cr.

Overview: <BR>Paramount Cosmetics (India) Ltd is a micro-cap company in the FMCG industry that manufactures and markets indigenous and western cosmetic products.<BR><BR>History: <BR>The company was incorporated in November 1985 and was formerly known as Tips & Toes Cosmetics Ltd. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 60 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 0 Cr (Quarterly Results - Mar 2025) <BR>Market-cap: INR 21 Cr (Micro Cap) <BR><BR>Key Metrics: <BR>P/E: 20.00 <BR>Industry P/E: 56 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.52 <BR>Return on Equity: 0.10% <BR>Price to Book: 1.01 <BR><BR>Contact Details: <BR>Address: A-1 2211 3rd Phase, GIDC Vapi Valsad Gujarat : 396195 <BR>Tel: 91-80-2532 0870/71 <BR>Email: compliance.officer@parammount.com <BR>Website: http://www.parammount.com

Who are the top shareholders of the Paramount Cosmet?

The top shareholder of Paramount Cosmet is Hiitesh Topiiwaalla, who holds 52.79% of the shares. There are no pledged promoter holdings, and individual investors own 20.19% of the shares, with no mutual funds or foreign institutional investors currently involved.

The top shareholders of Paramount Cosmet are primarily the promoters, with Hiitesh Topiiwaalla holding the largest share at 52.79%. There are no pledged promoter holdings, and currently, there are no mutual funds or foreign institutional investors (FIIs) holding shares in the company. Additionally, individual investors collectively hold 20.19% of the shares.

How big is Paramount Cosmet?

As of 24th July, Paramount Cosmetics (India) Ltd has a market capitalization of 20.00 Cr, with recent net sales of 20.39 Cr and a net profit of 0.02 Cr. Shareholder's funds are 20.31 Cr, and total assets are 40.41 Cr.

As of 24th July, Paramount Cosmetics (India) Ltd has a market capitalization of 20.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 20.39 Cr and a Net Profit of 0.02 Cr.<BR><BR>For the latest annual period ending March 2024, Shareholder's Funds were recorded at 20.31 Cr, while Total Assets amounted to 40.41 Cr.

How has been the historical performance of Paramount Cosmet?

Paramount Cosmet has experienced declining financial performance, with net sales dropping from 26.72 Cr in March 2023 to 20.38 Cr in March 2025, and profit after tax decreasing from 0.34 Cr in March 2021 to 0.03 Cr in March 2025, despite a reduction in total liabilities and assets. Operating profit has also shown volatility, falling to 0.98 Cr in March 2025.

Answer:<BR>The historical performance of Paramount Cosmet shows fluctuations in key financial metrics over the years, particularly in net sales, operating profit, and profit after tax.<BR><BR>Breakdown:<BR>Paramount Cosmet's net sales peaked at 26.72 Cr in March 2023 but have since declined to 20.38 Cr by March 2025. The total operating income followed a similar trend, decreasing from 26.72 Cr in March 2023 to 20.38 Cr in March 2025. The company experienced a significant reduction in raw material costs, which dropped to zero in March 2025 from 5.80 Cr in March 2023. However, the purchase of finished goods surged to 17.33 Cr in March 2025, contributing to total expenditure of 19.40 Cr for the same period. Operating profit (PBDIT) has shown volatility, with a high of 3.96 Cr in March 2020, but falling to 0.98 Cr in March 2025. Profit before tax and profit after tax also reflected this downward trend, with profit after tax declining to 0.03 Cr in March 2025 from a high of 0.34 Cr in March 2021. The company's total liabilities decreased from 48.75 Cr in March 2020 to 40.04 Cr in March 2025, while total assets also fell from 48.75 Cr to 40.04 Cr over the same period. Cash flow from operating activities remained stagnant, with no net cash inflow or outflow reported in recent years. Overall, Paramount Cosmet's financial performance has been characterized by declining sales and profits, alongside a reduction in liabilities and assets.

Is Paramount Cosmet overvalued or undervalued?

As of December 2, 2025, Paramount Cosmet's valuation has improved to very attractive, indicating it is undervalued compared to peers like Hindustan Unilever and Nestle India, with a high PE ratio of 303.92, yet it has recently outperformed the Sensex with a 1-week return of 4.33%.

As of 2 December 2025, the valuation grade for Paramount Cosmet has moved from attractive to very attractive, indicating a significant positive shift in its perceived value. The company is currently considered undervalued, especially when compared to its peers in the FMCG sector. Notable headline ratios include a PE Ratio of 303.92, an EV to EBITDA of 22.09, and a Price to Book Value of 0.89, which suggests that the stock may be mispriced relative to its intrinsic value.<BR><BR>In comparison to peers, Hindustan Unilever has a PE Ratio of 55.03 and an EV to EBITDA of 39.00, while Nestle India shows a PE of 81.19 and an EV to EBITDA of 50.36, both of which are significantly lower than Paramount's ratios. This highlights that Paramount Cosmet may offer a more attractive investment opportunity despite its high PE ratio. Additionally, while the company's recent stock performance has lagged behind the Sensex over the past year, it has outperformed in the short term, with a 1-week return of 4.33% compared to the Sensex's 0.65%.

When is the next results date for Paramount Cosmetics (India) Ltd?

The next results date for Paramount Cosmetics (India) Ltd is February 9, 2026.

The next results date for Paramount Cosmetics (India) Ltd is scheduled for February 9, 2026.

Are Paramount Cosmetics (India) Ltd latest results good or bad?

Paramount Cosmetics (India) Ltd's latest results show strong revenue growth of 85.68% quarter-on-quarter, but profitability remains a concern with a declining operating profit margin and modest net profit. While sales are increasing, high debt levels and weak return metrics suggest challenges in achieving sustainable profitability.

Paramount Cosmetics (India) Ltd's latest results present a mixed picture. On one hand, the company achieved significant revenue growth, with net sales increasing by 85.68% quarter-on-quarter and 69.40% year-on-year, reaching ₹8.69 crores in Q2 FY26. This indicates strong demand for its cosmetics products under brands like Tips & Toes, Shilpa, and Shingar.<BR><BR>However, the profitability metrics reveal concerning trends. The operating profit margin has contracted sharply from 9.40% in the previous quarter to 4.72%, indicating deteriorating operational efficiency despite the revenue growth. While the company did report a positive net profit of ₹0.12 crores, this is a modest figure and highlights the challenges it faces in maintaining consistent profitability. The PAT margin improved to 1.38% from negative territory, but overall, the company's profitability remains fragile.<BR><BR>The financial performance is further complicated by high leverage, with a debt-to-EBITDA ratio of 7.53 times, and weak return metrics, such as a return on equity (ROE) of only 3.63%. This suggests that while the company is growing its top line, it struggles to convert that growth into meaningful profits.<BR><BR>In summary, while the topline growth is encouraging, the underlying profitability issues and operational challenges indicate that the latest results are not entirely positive. Investors should be cautious, as the company faces significant hurdles in achieving sustainable profitability.

Should I buy, sell or hold Paramount Cosmetics (India) Ltd?

Which are the latest news on Paramount Cosmet?

Why is Paramount Cosmetics (India) Ltd falling/rising?

As of 11-Feb, the stock price of Paramount Cosmetics (India) Ltd is at 37.90, with mixed performance indicators. Despite recent short-term gains, the stock has significantly underperformed over the past year and is experiencing declining investor interest.

As of 11-Feb, the stock price of Paramount Cosmetics (India) Ltd is currently at 37.90, showing no change from the previous day. The stock has experienced a mixed performance over various time periods. In the last week, it has risen by 2.10%, outperforming the Sensex, which increased by only 0.50%. Over the past month, the stock has also shown a positive return of 3.86%, compared to the Sensex's 0.79% increase.<BR><BR>However, the year-to-date performance indicates a slight decline of 0.24%, while the Sensex has fallen by 1.16%. Over the past year, the stock has significantly underperformed, dropping 15.78%, while the Sensex has gained 10.41%. In the longer term, the stock has shown resilience, with a 3-year increase of 2.43% compared to the Sensex's 38.81% rise, and an impressive 115.34% increase over the past 5 years, outpacing the Sensex's 63.46% growth.<BR><BR>Today's performance indicates that the stock has underperformed its sector by 0.39%. Additionally, the stock's moving averages show that it is higher than the 5-day, 20-day, 50-day, and 100-day moving averages but lower than the 200-day moving average, suggesting some short-term strength but longer-term weakness. Furthermore, there has been a notable decline in investor participation, with a delivery volume of 221 on February 10, which is down by 48.2% compared to the 5-day average. This decline in trading volume may indicate reduced interest from investors, which could contribute to the stock's lack of upward momentum.<BR><BR>In summary, while there are some short-term gains, the overall trend shows significant underperformance over the past year and declining investor participation, which may be contributing to the stock's stagnation at its current price.